Regained compliance with Nasdaq listing requirements following Board appointments and completion of 1-for-20 reverse stock ...
GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
Several companies such as Shriram Finance, Symphony, etc. will be in focus today on account of corporate actions.
Pharma giant GSK is quitting BIO in latest setback… Pharma giant GSK is quitting BIO in latest setback for the lobbying group ...